Form 8-K - Current report:
SEC Accession No. 0001193125-25-005028
Filing Date
2025-01-13
Accepted
2025-01-13 08:30:21
Documents
57
Period of Report
2025-01-13
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d908680d8k.htm   iXBRL 8-K 25517
2 EX-99.1 d908680dex991.htm EX-99.1 67716
6 GRAPHIC g908680ex99_1p10g1.jpg GRAPHIC 231223
7 GRAPHIC g908680ex99_1p11g1.jpg GRAPHIC 253795
8 GRAPHIC g908680ex99_1p12g1.jpg GRAPHIC 246671
9 GRAPHIC g908680ex99_1p13g1.jpg GRAPHIC 272276
10 GRAPHIC g908680ex99_1p14g1.jpg GRAPHIC 300601
11 GRAPHIC g908680ex99_1p15g1.jpg GRAPHIC 326830
12 GRAPHIC g908680ex99_1p16g1.jpg GRAPHIC 234473
13 GRAPHIC g908680ex99_1p17g1.jpg GRAPHIC 421158
14 GRAPHIC g908680ex99_1p18g1.jpg GRAPHIC 389004
15 GRAPHIC g908680ex99_1p19g1.jpg GRAPHIC 202231
16 GRAPHIC g908680ex99_1p1g1.jpg GRAPHIC 307388
17 GRAPHIC g908680ex99_1p20g1.jpg GRAPHIC 315817
18 GRAPHIC g908680ex99_1p21g1.jpg GRAPHIC 333700
19 GRAPHIC g908680ex99_1p22g1.jpg GRAPHIC 245660
20 GRAPHIC g908680ex99_1p23g1.jpg GRAPHIC 249382
21 GRAPHIC g908680ex99_1p24g1.jpg GRAPHIC 325237
22 GRAPHIC g908680ex99_1p25g1.jpg GRAPHIC 359230
23 GRAPHIC g908680ex99_1p26g1.jpg GRAPHIC 265693
24 GRAPHIC g908680ex99_1p27g1.jpg GRAPHIC 263879
25 GRAPHIC g908680ex99_1p28g1.jpg GRAPHIC 309916
26 GRAPHIC g908680ex99_1p29g1.jpg GRAPHIC 265950
27 GRAPHIC g908680ex99_1p2g1.jpg GRAPHIC 482360
28 GRAPHIC g908680ex99_1p30g1.jpg GRAPHIC 223891
29 GRAPHIC g908680ex99_1p31g1.jpg GRAPHIC 276973
30 GRAPHIC g908680ex99_1p32g1.jpg GRAPHIC 265015
31 GRAPHIC g908680ex99_1p33g1.jpg GRAPHIC 359980
32 GRAPHIC g908680ex99_1p34g1.jpg GRAPHIC 215215
33 GRAPHIC g908680ex99_1p35g1.jpg GRAPHIC 220608
34 GRAPHIC g908680ex99_1p36g1.jpg GRAPHIC 247438
35 GRAPHIC g908680ex99_1p37g1.jpg GRAPHIC 225518
36 GRAPHIC g908680ex99_1p38g1.jpg GRAPHIC 256837
37 GRAPHIC g908680ex99_1p39g1.jpg GRAPHIC 294758
38 GRAPHIC g908680ex99_1p3g1.jpg GRAPHIC 313336
39 GRAPHIC g908680ex99_1p40g1.jpg GRAPHIC 368401
40 GRAPHIC g908680ex99_1p41g1.jpg GRAPHIC 319520
41 GRAPHIC g908680ex99_1p42g1.jpg GRAPHIC 251571
42 GRAPHIC g908680ex99_1p43g1.jpg GRAPHIC 313406
43 GRAPHIC g908680ex99_1p4g1.jpg GRAPHIC 344312
44 GRAPHIC g908680ex99_1p5g1.jpg GRAPHIC 251513
45 GRAPHIC g908680ex99_1p6g1.jpg GRAPHIC 307449
46 GRAPHIC g908680ex99_1p7g1.jpg GRAPHIC 326232
47 GRAPHIC g908680ex99_1p8g1.jpg GRAPHIC 371646
48 GRAPHIC g908680ex99_1p9g1.jpg GRAPHIC 330855
  Complete submission text file 0001193125-25-005028.txt   17724016

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA oric-20250113.xsd EX-101.SCH 2859
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE oric-20250113_lab.xml EX-101.LAB 18737
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE oric-20250113_pre.xml EX-101.PRE 11713
59 EXTRACTED XBRL INSTANCE DOCUMENT d908680d8k_htm.xml XML 3779
Mailing Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 388-5600
Oric Pharmaceuticals, Inc. (Filer) CIK: 0001796280 (see all company filings)

EIN.: 471787157 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39269 | Film No.: 25524965
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)